Location: New York, NY
CIK: 0001263508 · Show all filings
Period: Q3 2018 (← Previous) (Next →)
Filing Date: Nov 14, 2018
Total Value: $15.18B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Seattle Genetics, Inc. | 51,046,060 | $3.937B | 25.9% | $37.84 | — | COM | 812578102 |
| INCY | Incyte Corporation | 34,251,309 | $2.366B | 15.6% | $73.07 | -6.1% | COM | 45337C102 |
| ONC | BeiGene, Ltd. | 11,959,824 | $2.06B | 13.6% | $117.58 | — | SPONSORED ADR | 07725L102 |
| — | Alexion Pharmaceuticals, Inc. | 8,555,894 | $1.189B | 7.8% | $166.88 | — | COM | 015351109 |
| — | Genomic Health, Inc. | 13,790,970 | $968M | 6.4% | $31.71 | — | COM | 37244C101 |
| BMRN | BioMarin Pharmaceutical Inc. | 7,583,084 | $735M | 4.8% | $81.02 | +23.2% | COM | 09061G101 |
| ACAD | ACADIA Pharmaceuticals Inc. | 28,439,114 | $590M | 3.9% | $17.16 | -8.3% | COM | 004225108 |
| — | Amarin Corporation plc | 34,069,509 | $554M | 3.7% | $7.54 | — | SPONSORED ADR | 023111206 |
| MDGL | Madrigal Pharmaceuticals, Inc. | 1,169,278 | $250M | 1.6% | $110.87 | +126.3% | COM | 558868105 |
| ASND | Ascendis Pharma A/S | 2,837,352 | $201M | 1.3% | $29.89 | — | SPONSORED ADR | 04351P101 |
| HRTX | Heron Therapeutics, Inc. | 5,025,298 | $159M | 1.0% | $17.34 | +114.8% | COM | 427746102 |
| — | Invitae Corporation | 8,399,411 | $141M | 0.9% | $14.39 | — | COM | 46185L103 |
| — | DBV Technologies S.A. | 5,509,560 | $124M | 0.8% | $32.87 | — | SPONSORED ADR | 23306J101 |
| — | Mirati Therapeutics, Inc. | 2,513,462 | $118M | 0.8% | $18.61 | — | COM | 60468T105 |
| NBIX | Neurocrine Biosciences, Inc. | 944,624 | $116M | 0.8% | $44.09 | +157.3% | COM | 64125C109 |
| BCRX | BioCryst Pharmaceuticals, Inc. | 15,103,081 | $115M | 0.8% | $6.96 | -3.5% | COM | 09058V103 |
| — | Array BioPharma Inc. | 5,656,196 | $85.97M | 0.6% | $10.76 | — | COM | 04269X105 |
| — | Sage Therapeutics, Inc. | 567,497 | $80.16M | 0.5% | $92.31 | — | COM | 78667J108 |
| RYTM | Rhythm Pharmaceuticals, Inc. | 2,708,200 | $79M | 0.5% | $26.63 | +18.7% | COM | 76243J105 |
| CERS | Cerus Corporation | 10,749,937 | $77.51M | 0.5% | $4.67 | +55.5% | COM | 157085101 |
| ARGX | argenx SE | 1,019,557 | $77.32M | 0.5% | $59.75 | — | SPONSORED ADR | 04016X101 |
| — | Kiniksa Pharmaceuticals, Ltd. | 3,000,000 | $76.5M | 0.5% | $17.35 | — | COM CL A | G5269C101 |
| — | Spark Therapeutics, Inc. | 1,384,130 | $75.5M | 0.5% | $76.99 | — | COM | 84652J103 |
| — | GW Pharmaceuticals plc | 396,700 | $68.53M | 0.5% | $135.83 | — | ADS | 36197T103 |
| — | CymaBay Therapeutics, Inc. | 4,917,700 | $54.49M | 0.4% | $8.94 | — | COM | 23257D103 |
| — | Principia Biopharma Inc. | 1,787,807 | $52.24M | 0.3% | $29.22 | — | COM | 74257L108 |
| — | Tricida, Inc. | 1,600,000 | $48.88M | 0.3% | $29.90 | — | COM | 89610F101 |
| — | Endocyte, Inc. | 2,548,069 | $45.25M | 0.3% | $7.96 | — | COM | 29269A102 |
| — | Idera Pharmaceuticals, Inc. | 4,833,897 | $43.07M | 0.3% | $1.32 | — | COM | 45168K405 |
| — | Corsicanto II Designated Activity Company | 10,000,000 | $41.75M | 0.3% | $1.10 | — | NOTE 3.5% 1/5/2047 | 220485AB2 |
| INSM | Insmed Incorporated | 1,851,982 | $37.45M | 0.2% | $20.25 | +11.6% | COM PAR $.01 | 457669307 |
| — | Aquinox Pharmaceuticals, Inc. | 10,934,154 | $32.04M | 0.2% | $13.36 | — | COM | 03842B101 |
| — | Abeona Therapeutics Inc. | 2,184,364 | $27.96M | 0.2% | $7.28 | — | COM | 00289Y107 |
| — | Solid Biosciences Inc. | 587,884 | $27.74M | 0.2% | $7.50 | — | COM | 83422E105 |
| GLPG | Galapagos NV | 237,191 | $26.67M | 0.2% | $51.50 | — | SPONSORED ADR | 36315X101 |
| XNCR | Xencor, Inc. | 602,495 | $23.48M | 0.2% | $11.07 | +268.5% | COM | 98401F105 |
| — | MyoKardia, Inc. | 357,215 | $23.29M | 0.2% | $40.09 | — | COM | 62857M105 |
| — | Merus N.V. | 1,160,014 | $22.9M | 0.2% | $8.27 | — | COM | N5749R100 |
| QURE | uniQure N.V. | 605,000 | $22.02M | 0.1% | $18.33 | +102.9% | SHS | N90064101 |
| SGMO | Sangamo Therapeutics, Inc. | 1,283,923 | $21.76M | 0.1% | $11.28 | +34.7% | COM | 800677106 |
| — | Clementia Pharmaceuticals Inc. | 1,933,624 | $21.56M | 0.1% | $12.87 | — | COM | 185575107 |
| — | Zymeworks Inc. | 1,311,085 | $20.58M | 0.1% | $14.78 | — | COM | 98985W102 |
| — | Aimmune Therapeutics, Inc. | 673,908 | $18.38M | 0.1% | $16.20 | — | COM | 00900T107 |
| — | Neurocrine Biosciences, Inc. | 10,000,000 | $17.06M | 0.1% | $1.45 | — | NOTE 2.25% 5/15/2024 | 64125CAD1 |
| — | Bellicum Pharmaceuticals, Inc. | 2,677,818 | $16.5M | 0.1% | $22.31 | — | COM | 079481107 |
| — | BioMarin Pharmaceutical Inc. | 15,000,000 | $15.82M | 0.1% | $1.01 | — | NOTE 0.599% 8/1/2024 | 09061GAH4 |
| — | Audentes Therapeutics, Inc. | 393,222 | $15.57M | 0.1% | $30.05 | — | COM | 05070R104 |
| — | ContraFect Corporation | 7,153,076 | $14.81M | 0.1% | $1.88 | — | COM | 212326102 |
| — | Aeglea BioTherapeutics, Inc. | 1,387,872 | $13.28M | 0.1% | $5.20 | — | COM | 00773J103 |
| — | BioMarin Pharmaceutical Inc. | 12,228,000 | $12.6M | 0.1% | $1.06 | — | NOTE 0.75% 10/15/2018 | 09061GAE1 |
| ANAB | AnaptysBio, Inc. | 113,086 | $11.28M | 0.1% | $56.96 | +45.7% | COM | 032724106 |
| CPRX | Catalyst Pharmaceuticals, Inc. | 2,900,000 | $10.96M | 0.1% | $2.70 | +16.0% | COM | 14888U101 |
| — | ERYTECH Pharma S.A. | 1,085,969 | $9.307M | 0.1% | $22.02 | — | SPONSORED ADR | 29604W108 |
| — | Novavax, Inc. | 4,718,318 | $8.87M | 0.1% | $1.88 | — | COM | 670002104 |
| — | bluebird bio, Inc. | 59,441 | $8.678M | 0.1% | $41.25 | — | COM | 09609G100 |
| — | Albireo Pharma, Inc. | 250,000 | $8.24M | 0.1% | $22.99 | — | COM | 01345P106 |
| HALO | Halozyme Therapeutics, Inc. | 449,969 | $8.176M | 0.1% | $7.32 | +139.2% | COM | 40637H109 |
| — | Momenta Pharmaceuticals, Inc. | 308,500 | $8.114M | 0.1% | $18.15 | — | COM | 60877T100 |
| VKTX | Viking Therapeutics, Inc. | 425,000 | $7.404M | 0.0% | $11.90 | 0.0% | COM | 92686J106 |
| — | Spring Bank Pharmaceuticals, Inc. | 613,144 | $7.388M | 0.0% | $10.97 | — | COM | 849431101 |
| AUTL | Autolus Therapeutics plc | 235,294 | $7.216M | 0.0% | $26.79 | — | SPON ADS | 05280R100 |
| — | Menlo Therapeutics Inc. | 700,000 | $6.895M | 0.0% | $37.58 | — | COM | 586858102 |
| — | Syros Pharmaceuticals, Inc. | 574,835 | $6.846M | 0.0% | $16.82 | — | COM | 87184Q107 |
| — | G1 Therapeutics, Inc. | 127,236 | $6.653M | 0.0% | $37.05 | — | COM | 3621LQ109 |
| IFRX | InflaRx N.V. | 178,987 | $6.143M | 0.0% | $21.73 | +48.4% | COM | N44821101 |
| — | Achillion Pharmaceuticals, Inc. | 1,639,948 | $6.035M | 0.0% | $6.34 | — | COM | 00448Q201 |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 307,496 | $5.895M | 0.0% | $16.41 | 0.0% | COM | 04280A100 |
| — | Assembly Biosciences, Inc. | 148,587 | $5.519M | 0.0% | $20.45 | — | COM | 045396108 |
| NTLA | Intellia Therapeutics, Inc. | 192,538 | $5.51M | 0.0% | $26.35 | +10.4% | COM | 45826J105 |
| — | ChemoCentryx, Inc. | 414,029 | $5.233M | 0.0% | $13.66 | — | COM | 16383L106 |
| — | Aevi Genomic Medicine, Inc. | 3,950,419 | $4.859M | 0.0% | $2.12 | — | COM | 00835P105 |
| — | Acceleron Pharma Inc. | 83,900 | $4.802M | 0.0% | $37.72 | — | COM | 00434H108 |
| — | Galmed Pharmaceuticals Ltd. | 324,094 | $4.401M | 0.0% | $11.90 | — | SHS | M47238106 |
| ALKS | Alkermes plc | 100,251 | $4.255M | 0.0% | $70.02 | -38.0% | SHS | G01767105 |
| — | Y-mAbs Therapeutics, Inc. | 150,000 | $3.984M | 0.0% | $26.56 | — | COM | 984241109 |
| — | Foamix Pharmaceuticals Ltd. | 688,075 | $3.943M | 0.0% | $7.55 | — | SHS | M46135105 |
| CRNX | Crinetics Pharmaceuticals, Inc. | 131,250 | $3.76M | 0.0% | $29.69 | 0.0% | COM | 22663K107 |
| — | Forty Seven, Inc. | 250,000 | $3.73M | 0.0% | $16.00 | — | COM | 34983P104 |
| APLS | Apellis Pharmaceuticals, Inc. | 196,078 | $3.486M | 0.0% | $22.98 | -19.5% | COM | 03753U106 |
| — | Adamas Pharmaceuticals, Inc. | 172,630 | $3.456M | 0.0% | $14.46 | — | COM | 00548A106 |
| — | Versartis, Inc. | 2,426,310 | $3.397M | 0.0% | $14.17 | — | COM | 92529L102 |
| — | Ra Pharmaceuticals, Inc. | 177,952 | $3.219M | 0.0% | $15.19 | — | COM | 74933V108 |
| — | La Jolla Pharmaceutical Company | 154,675 | $3.114M | 0.0% | $29.30 | — | COM PAR $.0001 2 | 503459604 |
| — | Trillium Therapeutics Inc. | 505,262 | $2.931M | 0.0% | $12.19 | — | COM | 89620X506 |
| KRYS | Krystal Biotech, Inc. | 114,674 | $2.016M | 0.0% | $10.08 | +66.4% | COM | 501147102 |
| AQST | Aquestive Therapeutics, Inc. | 99,600 | $1.744M | 0.0% | $16.48 | 0.0% | COM | 03843E104 |
| RCUS | Arcus Biosciences, Inc. | 121,534 | $1.694M | 0.0% | $15.69 | -18.7% | COM | 03969F109 |
| INFIQ | Infinity Pharmaceuticals, Inc. | 580,400 | $1.573M | 0.0% | $1.54 | +34.7% | COM | 45665G303 |
| — | Molecular Templates, Inc. | 254,230 | $1.37M | 0.0% | $5.84 | — | COM | 608550109 |
| OVID | Ovid Therapeutics Inc. | 222,139 | $1.26M | 0.0% | $13.06 | -41.9% | COM | 690469101 |
| — | Sunesis Pharmaceuticals, Inc. | 556,665 | $1.113M | 0.0% | $4.37 | — | COM PAR | 867328700 |
| — | Dynavax Technologies Corporation | 75,000 | $930K | 0.0% | $24.55 | — | COM | 268158201 |
| — | Constellation Pharmaceuticals, Inc. | 133,333 | $897K | 0.0% | $6.73 | — | COM | 210373106 |
| — | Affimed N.V. | 200,000 | $870K | 0.0% | $6.30 | — | COM | N01045108 |
| — | Proteon Therapeutics, Inc. | 298,591 | $582K | 0.0% | $9.69 | — | COM | 74371L109 |
| — | Ritter Pharmaceuticals, Inc. | 279,999 | $521K | 0.0% | $2.72 | — | COM | 767836307 |
| FLGT | Fulgent Genetics, Inc. | 125,000 | $491K | 0.0% | $9.20 | -53.6% | COM | 359664109 |